Correlation of Wnt Antagonist SFPR1, Slug and β-catenin with Prognosis and Metastasis in Colorectal Carcinoma

Overview

Journal Int J Clin Exp Pathol

Specialty Pathology

Date 2020 Jan 16

PMID 31938110

Citations 1

Authors

Qiong Wu

Lei Zhou

Yan Yang

Yanzi Qin

Yurong Ou

Affiliations

Soon will be listed here.

Abstract

sFPR1 plays an important role in colorectal carcinoma (CRC) tumorigenesis, Slug is also considered to be related to the development of CRC. However, the relationship between them and the mechanism of their involvement in CRC metastasis remain unknown. In this study, immunohistochemistry (IHC) was used to detect the expression of sFPR1, β-catenin, and Slug in 145 samples of CRC and corresponding surrounding "normal" mucosa tissues. Furthermore, clinicopathological features such as age, sex and so on were also collected retrospectively. Western blot and Transwell were used to detect proteins expression and migration capacity. In present study, the expression of sFPR1, Slug and β-catenin proteins were significantly correlated with lymph node metastasis and tumor-node-metastasis (TNM) stage of patients with CRC. sFPR1 expression showed a negative correlation with Slug and β-catenin. Kaplan-Meier analysis indicated that the postoperative 5-year OS of patients was related to the expression of sFPR1 and Slug, multivariate Cox regression analysis revealed that sFPR1 expression was an independent prognostic factor for CRC patients. Moreover, we found that the expression of slug and β-catenin could be regulated by sFPR1 in SW480 cells, and migration capacity of SW480 cells was suppressed with sFPR1 restoration. In summary, our data suggest that sFRP1, Slug and β-catenin are related to metastasis and prognosis in CRC. sFPR1 could mediate CRC metastasis by regulating the expression of Slug and β-catenin. Combined detection of these factors may be of significant value in predicting the metastasis and prognosis in CRC patients.

Citing Articles

The correlation of KAI1, Slug and vasculogenic mimicry in the prediction of metastasis and prognosis in colorectal carcinoma.

Wang M, Wu Q, Jiang Y, Liu Y, Ou Y Int J Clin Exp Pathol. 2020; 11(10):5034-5043.

PMID: 31949580 PMC: 6962931.

References

Ou Y, Liu J, Gao S, Jing G, Cheng Z, Dong X . [Expression of secreted frizzled related protein 1, β-catenin and E-cadherin in colorectal carcinoma and its clinicopathological significances]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2014; 43(4):397-405. DOI: 10.3785/j.issn.1008-9292.2014.06.005. View

Nieto M . The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol. 2002; 3(3):155-66. DOI: 10.1038/nrm757. View

Chung M, Lai H, Sytwu H, Yan M, Shih Y, Chang C . SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway. Gynecol Oncol. 2008; 112(3):646-53. DOI: 10.1016/j.ygyno.2008.10.026. View

Chen W, Zheng R, Baade P, Zhang S, Zeng H, Bray F . Cancer statistics in China, 2015. CA Cancer J Clin. 2016; 66(2):115-32. DOI: 10.3322/caac.21338. View

Chen Z, He X, Jia M, Liu Y, Qu D, Wu D . β-catenin overexpression in the nucleus predicts progress disease and unfavourable survival in colorectal cancer: a meta-analysis. PLoS One. 2013; 8(5):e63854. PMC: 3663842. DOI: 10.1371/journal.pone.0063854. View

Mina L, Sledge Jr G . Rethinking the metastatic cascade as a therapeutic target. Nat Rev Clin Oncol. 2011; 8(6):325-32. DOI: 10.1038/nrclinonc.2011.59. View

Jiang G, Liu W, Cui Y, Zhong X, Tai S, Wang Z . Reconstitution of secreted frizzled-related protein 1 suppresses tumor growth and lung metastasis in an orthotopic model of hepatocellular carcinoma. Dig Dis Sci. 2009; 55(10):2838-43. DOI: 10.1007/s10620-009-1099-3. View

Mohammadi Ghahhari N, Babashah S . Interplay between microRNAs and WNT/β-catenin signalling pathway regulates epithelial-mesenchymal transition in cancer. Eur J Cancer. 2015; 51(12):1638-49. DOI: 10.1016/j.ejca.2015.04.021. View

Suzuki H, Gabrielson E, Chen W, Anbazhagan R, van Engeland M, Weijenberg M . A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet. 2002; 31(2):141-9. DOI: 10.1038/ng892. View

10.

Zhu Q, Gao R, Wu W, Qin H . Epithelial-mesenchymal transition and its role in the pathogenesis of colorectal cancer. Asian Pac J Cancer Prev. 2013; 14(5):2689-98. DOI: 10.7314/apjcp.2013.14.5.2689. View

11.

Tang M, Torres-Lanzas J, Lopez-Rios F, Esteller M, Sanchez-Cespedes M . Wnt signaling promoter hypermethylation distinguishes lung primary adenocarcinomas from colorectal metastasis to the lung. Int J Cancer. 2006; 119(11):2603-6. DOI: 10.1002/ijc.22211. View

12.

Zhang J, Tian X, Xing J . Signal Transduction Pathways of EMT Induced by TGF-β, SHH, and WNT and Their Crosstalks. J Clin Med. 2016; 5(4). PMC: 4850464. DOI: 10.3390/jcm5040041. View

13.

MacDonald B, Tamai K, He X . Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009; 17(1):9-26. PMC: 2861485. DOI: 10.1016/j.devcel.2009.06.016. View

14.

Silva A, Dawson S, Arends M, Guttula K, Hall N, Cameron E . Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists. BMC Cancer. 2014; 14:891. PMC: 4265460. DOI: 10.1186/1471-2407-14-891. View

15.

Ren J, Wang R, Huang G, Song H, Chen Y, Chen L . sFRP1 inhibits epithelial-mesenchymal transition in A549 human lung adenocarcinoma cell line. Cancer Biother Radiopharm. 2013; 28(7):565-71. PMC: 3741431. DOI: 10.1089/cbr.2012.1453. View

16.

Vincan E, Barker N . The upstream components of the Wnt signalling pathway in the dynamic EMT and MET associated with colorectal cancer progression. Clin Exp Metastasis. 2008; 25(6):657-63. DOI: 10.1007/s10585-008-9156-4. View

17.

Maruyama K, Ochiai A, Akimoto S, Nakamura S, Baba S, Moriya Y . Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer. Oncology. 2000; 59(4):302-9. DOI: 10.1159/000012187. View

18.

Caldwell G, Jones C, Gensberg K, Jan S, Hardy R, Byrd P . The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res. 2004; 64(3):883-8. DOI: 10.1158/0008-5472.can-03-1346. View

19.

Kongkham P, Northcott P, Croul S, Smith C, Taylor M, Rutka J . The SFRP family of WNT inhibitors function as novel tumor suppressor genes epigenetically silenced in medulloblastoma. Oncogene. 2010; 29(20):3017-24. DOI: 10.1038/onc.2010.32. View

20.

Flis S, Gnyszka A, Flis K . DNA methyltransferase inhibitors improve the effect of chemotherapeutic agents in SW48 and HT-29 colorectal cancer cells. PLoS One. 2014; 9(3):e92305. PMC: 3967992. DOI: 10.1371/journal.pone.0092305. View